Global Circulating Tumor Cells (CTC) Market Research Report 2023, Forecast to 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
are cells that have detached from a primary tumor and circulate in the bloodstream.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China’s reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Circulating Tumor Cells (CTC) industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
CTC Enrichment
CTC Detection
CTC Analysis
Market Segment by Product Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To study and analyze the global Circulating Tumor Cells (CTC) consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
2.To understand the structure of Circulating Tumor Cells (CTC) market by identifying its various subsegments.
3.Focuses on the key global Circulating Tumor Cells (CTC) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Circulating Tumor Cells (CTC) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Circulating Tumor Cells (CTC) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Circulating Tumor Cells (CTC) Market Research Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Circulating Tumor Cells (CTC) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Circulating Tumor Cells (CTC) Segment by Type
2.1.1 CTC Enrichment
2.1.2 CTC Detection
2.1.3 CTC Analysis
2.2 Market Analysis by Application
2.2.1 Breast Cancer
2.2.2 Prostate Cancer
2.2.3 Colorectal Cancer
2.2.4 Lung Cancer
2.2.5 Other
2.3 Global Circulating Tumor Cells (CTC) Market Comparison by Regions (2018-2028)
2.3.1 Global Circulating Tumor Cells (CTC) Market Size (2018-2028)
2.3.2 North America Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.3 Europe Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.4 China Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.5 Japan Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.6 Southeast Asia Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Circulating Tumor Cells (CTC) Industry Impact
2.5.1 Circulating Tumor Cells (CTC) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Circulating Tumor Cells (CTC) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Circulating Tumor Cells (CTC) Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Circulating Tumor Cells (CTC) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Circulating Tumor Cells (CTC) Manufacturer Market Share
3.5 Top 10 Circulating Tumor Cells (CTC) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Circulating Tumor Cells (CTC) Market
3.7 Key Manufacturers Circulating Tumor Cells (CTC) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Circulating Tumor Cells (CTC) Industry Key Manufacturers
4.1 Menarini-Silicon Biosystems
4.1.1 Compan Detail
4.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.1.3 Menarini-Silicon Biosystems 166 Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Menarini-Silicon Biosystems News
4.2 Qiagen (Adnagen)
4.2.1 Compan Detail
4.2.2 Qiagen (Adnagen) Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.2.3 Qiagen (Adnagen) Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Menarini-Silicon Biosystems News
4.3 Advanced Cell Diagnostics
4.3.1 Compan Detail
4.3.2 Advanced Cell Diagnostics Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Advanced Cell Diagnostics News
4.4 ApoCell
4.4.1 Compan Detail
4.4.2 ApoCell Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.4.3 ApoCell Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 ApoCell News
4.5 Epic Sciences
4.5.1 Compan Detail
4.5.2 ApoCell Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.5.3 Epic Sciences Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Epic Sciences News
4.6 Greiner Bio-one GmbH
4.6.1 Compan Detail
4.6.2 Greiner Bio-one GmbH Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.6.3 Greiner Bio-one GmbH Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Greiner Bio-one GmbH News
4.7 Cynvenio
4.7.1 Compan Detail
4.7.2 Cynvenio Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.7.3 Cynvenio Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 SurExamBio-Tech
4.8.1 Compan Detail
4.8.2 SurExamBio-Tech Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.8.3 SurExamBio-Tech Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 SurExamBio-Tech News
4.9 Fluxion Biosciences
4.9.1 Compan Detail
4.9.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.9.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Fluxion Biosciences News
4.10 Ikonisys
4.10.1 Compan Detail
4.10.2 Ikonisys Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.10.3 Ikonisys Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 Ikonisys News
4.11 Hangzhou Watson Biotech
4.11.1 Compan Detail
4.11.2 Hangzhou Watson Biotech Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.11.3 Hangzhou Watson Biotech Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.11.4 Main Business Overview
4.11.5 Hangzhou Watson Biotech News
4.12 Biocept
4.12.1 Compan Detail
4.12.2 Biocept Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.12.3 Biocept Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.12.4 Main Business Overview
4.12.5 Biocept News
4.13 CytoTrack
4.13.1 Company Details
4.13.2 CytoTrack Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.13.3 CytoTrack Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.13.4 Main Business Overview
4.13.5 CytoTrack News
4.14 Guangzhou Wondfo Biotech
4.14.1 Compan Detail
4.14.2 Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.14.4 Main Business Overview
4.14.5 Guangzhou Wondfo Biotech News
4.15 Celsee
4.15.1 Compan Detail
4.15.2 Celsee Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.15.3 Celsee Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.15.4 Main Business Overview
4.15.5 Celsee News
4.16 Clearbridge Biomedics
4.16.1 Compan Detail
4.16.2 Clearbridge Biomedics Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.16.3 Clearbridge Biomedics Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.16.4 Main Business Overview
4.16.5 Clearbridge Biomedics News
4.17 ANGLE plc
4.17.1 Compan Detail
4.17.2 ANGLE plc Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.17.3 ANGLE plc Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.17.4 Main Business Overview
4.17.5 ANGLE plc News
4.18.1 Compan Detail
5 Global Circulating Tumor Cells (CTC) Market Segment by Big Type
5.1 Global Circulating Tumor Cells (CTC) Revenue, Sales and Market Share by Big Type (2018-2023)
5.1.1 Global Circulating Tumor Cells (CTC) Sales and Market Share by Big Type (2018-2023)
5.1.2 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Big Type (2018-2023)
5.2 CTC Enrichment Sales Growth Rate and Price
5.2.1 Global CTC Enrichment Sales Growth Rate (2018-2023)
5.2.2 Global CTC Enrichment Price (2018-2023)
5.3 CTC Detection Sales Growth Rate and Price
5.3.1 Global CTC Detection Sales Growth Rate (2018-2023)
5.3.2 Global CTC Detection Price (2018-2023)
5.4 CTC Analysis Sales Growth Rate and Price
5.4.1 Global CTC Analysis Sales Growth Rate (2018-2023)
5.4.2 Global CTC Analysis Price (2018-2023)
6 Global Circulating Tumor Cells (CTC) Market Segment by Big Application
6.1 Global Circulating Tumor Cells (CTC) Sales Market Share by Big Application (2018-2023)
6.2 Breast Cancer Sales Growth Rate (2018-2023)
6.3 Prostate Cancer Sales Growth Rate (2018-2023)
6.4 Colorectal Cancer Sales Growth Rate (2018-2023)
6.5 Lung Cancer Sales Growth Rate (2018-2023)
6.6 Other Sales Growth Rate (2018-2023)
7 Global Circulating Tumor Cells (CTC) Forecast
7.1 Global Circulating Tumor Cells (CTC) Revenue, Sales and Growth Rate (2023-2028)
7.2 Circulating Tumor Cells (CTC) Market Forecast by Regions (2023-2028)
7.2.1 North America Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
7.2.2 Europe Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
7.2.3 China Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
7.2.4 Japan Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
7.2.5 Southeast Asia Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
7.2.6 Other Regions Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
7.3 Circulating Tumor Cells (CTC) Market Forecast by Type (2023-2028)
7.3.1 Global Circulating Tumor Cells (CTC) Sales Forecast by Type (2023-2028)
7.3.2 Global Circulating Tumor Cells (CTC) Market Share Forecast by Type (2023-2028)
7.4 Circulating Tumor Cells (CTC) Market Forecast by Application (2023-2028)
7.4.1 Global Circulating Tumor Cells (CTC) Sales Forecast by Application (2023-2028)
7.4.2 Global Circulating Tumor Cells (CTC) Market Share Forecast by Application (2023-2028)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Circulating Tumor Cells (CTC) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Circulating Tumor Cells (CTC) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Circulating Tumor Cells (CTC)
Figure Market Concentration Ratio and Market Maturity Analysis of Circulating Tumor Cells (CTC)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Circulating Tumor Cells (CTC) Market Size by Big Type
Figure Global Market Share of Circulating Tumor Cells (CTC) by Big Type in 2022
Figure CTC Enrichment Picture (2018-2023)
Figure CTC Detection Picture (2018-2023)
Global Circulating Tumor Cells (CTC) Market Size by Big Application
Table Global Circulating Tumor Cells (CTC) Market Size by Application
Figure Global Circulating Tumor Cells (CTC) Market Share by Big Application in 2022
Figure Breast Cancer Picture
Figure Prostate Cancer Picture
Figure Colorectal Cancer Picture
Figure Lung Cancer Picture
Figure Other Picture
Table Global Circulating Tumor Cells (CTC) Comparison by Regions (M USD) （2018-2028）
Figure Global Circulating Tumor Cells (CTC) Market Size (Million US$) (2018-2028)
Figure North America Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure China Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure Japan Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure Southeast Asia Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Circulating Tumor Cells (CTC) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Circulating Tumor Cells (CTC) Sales by Manufacturer (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Sales Market Share by Manufacturer in 2022
Table Global Circulating Tumor Cells (CTC) Revenue by Manufacturer (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Revenue Market Share by Manufacturer in 2022
Table Global Circulating Tumor Cells (CTC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Circulating Tumor Cells (CTC) Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Circulating Tumor Cells (CTC) Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Circulating Tumor Cells (CTC) Market
Table Key Manufacturers Circulating Tumor Cells (CTC) Product Type
Table Mergers & Acquisitions Planning
Table Menarini-Silicon Biosystems Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Menarini-Silicon Biosystems
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2018-2023
Table Company One Main Business
Table Company One Recent Development
Table Qiagen (Adnagen) Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Qiagen (Adnagen)
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Qiagen (Adnagen) Recent Development
Table Advanced Cell Diagnostics Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Advanced Cell Diagnostics
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Advanced Cell Diagnostics Main Business
Table Advanced Cell Diagnostics Recent Development
Table ApoCell Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of ApoCell
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table ApoCell Main Business
Table ApoCell Recent Development
Table ApoCell Main Business
Table ApoCell Recent Development
Table Epic Sciences Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Epic Sciences
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Epic Sciences Main Business
Table Epic Sciences Recent Development
Table Greiner Bio-one GmbH Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Greiner Bio-one GmbH
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Greiner Bio-one GmbH Main Business
Table Greiner Bio-one GmbH Recent Development
Table Cynvenio Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Cynvenio
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Cynvenio Main Business
Table Cynvenio Recent Development
Table SurExamBio-Tech Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of SurExamBio-Tech
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table SurExamBio-Tech Main Business
Table SurExamBio-Tech Recent Development
Table Fluxion Biosciences Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Fluxion Biosciences
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Fluxion Biosciences Main Business
Table Fluxion Biosciences Recent Development
Table Ikonisys Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Ikonisys
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Ikonisys Main Business
Table Ikonisys Recent Development
Table Hangzhou Watson Biotech Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Hangzhou Watson Biotech
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Hangzhou Watson Biotech Main Business
Table Hangzhou Watson Biotech Recent Development
Table Biocept Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Biocept
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Biocept Main Business
Table Biocept Recent Development
Table CytoTrack Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of CytoTrack
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table CytoTrack Main Business
Table CytoTrack Recent Development
Table Guangzhou Wondfo Biotech Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Guangzhou Wondfo Biotech
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Guangzhou Wondfo Biotech Main Business
Table Guangzhou Wondfo Biotech Recent Development
Table Clearbridge Biomedics Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Clearbridge Biomedics
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Clearbridge Biomedics Main Business
Table Clearbridge Biomedics Recent Development
Table ANGLE plc Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of ANGLE plc
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table ANGLE plc Main Business
Table ANGLE plc Recent Development
Figure Global Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Revenue and Growth Rate (2018-2023)
Table Global Circulating Tumor Cells (CTC) Sales by Regions (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Sales Market Share by Regions in 2022
Table Global Circulating Tumor Cells (CTC) Revenue by Regions (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Revenue Market Share by Regions in 2022
Figure North America Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Europe Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure China Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Japan Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Southeast Asia Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Other Regions Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Table Global Circulating Tumor Cells (CTC) Sales by Big Type (2018-2023)
Table Global Circulating Tumor Cells (CTC) Sales Market Share by Big Type (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Sales Market Share by Big Type in 2020
Table Global Circulating Tumor Cells (CTC) Revenue by Big Type (2018-2023)
Table Global Circulating Tumor Cells (CTC) Revenue Market Share by Big Type (2018-2023)
Table Global Circulating Tumor Cells (CTC) Revenue Market Share by Big Type in 2020
Figure Global CTC Enrichment Sales Growth Rate (2018-2023)
Figure Global CTC Enrichment Price (2018-2023)
Figure Global CTC Detection Sales Growth Rate (2018-2023)
Figure Global CTC Detection Price (2018-2023)
Figure Global CTC Analysis Sales Growth Rate (2018-2023)
Table Global Circulating Tumor Cells (CTC) Sales by Big Application (2018-2023)
Table Global Circulating Tumor Cells (CTC) Sales Market Share by Big Application (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Sales Market Share by Big Application in 2020
Figure Global Breast Cancer Sales Growth Rate (2018-2023)
Figure Global Prostate Cancer Sales Growth Rate (2018-2023)
Figure Global Colorectal Cancer Sales Growth Rate (2018-2023)
Figure Global Lung Cancer Sales Growth Rate (2018-2023)
Figure Global Other Sales Growth Rate (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Sales and Growth Rate (2023-2028)
Figure Global Circulating Tumor Cells (CTC) Revenue and Growth Rate (2023-2028)
Table Global Circulating Tumor Cells (CTC) Sales Forecast by Regions (2023-2028)
Table Global Circulating Tumor Cells (CTC) Market Share Forecast by Regions (2023-2028)
Figure North America Sales Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
Figure Europe Sales Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
Figure China Sales Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
Figure Japan Sales Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
Figure Southeast Asia Sales Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
Figure Other Regions Sales Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
Table Global Circulating Tumor Cells (CTC) Sales Forecast by Type (2023-2028)
Table Global Circulating Tumor Cells (CTC) Market Share Forecast by Type (2023-2028)
Table Global Circulating Tumor Cells (CTC) Sales Forecast by Application (2023-2028)
Table Global Circulating Tumor Cells (CTC) Market Share Forecast by Application (2023-2028)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Circulating Tumor Cells (CTC)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Circulating Tumor Cells (CTC) Sales (K Units) Growth Rate Forecast (2022-2026)
Figure North America Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Europe Circulating Tumor Cells (CTC) Sales (K Units) Growth Rate Forecast (2022-2026)
Figure Europe Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Japan Circulating Tumor Cells (CTC) Production (K Units) Growth Rate Forecast (2022-2026)
Figure Japan Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure China Circulating Tumor Cells (CTC) Production (K Units) Growth Rate Forecast (2022-2026)
Figure China Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Research Methodology:
Global Circulating Tumor Cells (CTC) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|